News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
Presentation EuroPCR 2024 Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial Presenter: Patrick Serruys May 15, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2019 Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis L.A. McKeown June 07, 2019
News Conference News EuroPCR 2019 Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS Michael O'Riordan May 21, 2019
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease Yael L. Maxwell May 22, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Conference News EuroPCR 2017 Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate Michael O'Riordan May 15, 2017
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
Presentation EuroPCR 2016 Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome Presenter: Patrick Serruys May 20, 2016
News Conference News EuroPCR 2014 CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device Caitlin E. Cox May 20, 2014
News Conference News EuroPCR 2012 Thrombectomy Results Underwhelming in AMI Patients Jason Kahn May 17, 2012
News Conference News Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years Caitlin E. Cox May 20, 2011